title: Daclizumab in multiple sclerosis: a high-yield extension study.
authors.affiliation: Department of Radiology and Nuclear Medicine, VU University Medical Centre, PO Box 7057, 1007 MB Amsterdam, Netherlands. Electronic address: f.barkhof@vumc.nl.
authors.forename: Frederik
authors.initials: F
authors.lastname: Barkhof
authors.affiliation: Queen Square Centre, University College London Institute of Neurology, University College London, London, UK; National Institute for Health Research Biomedical Research Centre, University College London Hospitals, London, UK.
authors.forename: Olga
authors.initials: O
authors.lastname: Ciccarelli
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D000077561:Daclizumab; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000627:therapeutic use*; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008297:Male; D020529:Multiple Sclerosis, Relapsing-Remitting / Q000188:drug therapy*
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D007074:Immunoglobulin G; D007166:Immunosuppressive Agents; D000077561:Daclizumab